Table 1 Summary of ABS-VIR-001 potency against key variants throughout the pandemic.

From: First-in-class trispecific VHH-Fc based antibody with potent prophylactic and therapeutic efficacy against SARS-CoV-2 and variants

 

Binding

Blocking

Wild-type

 +  +  + 

 +  +  + 

Other variants (Alpha/Beta)

 +  +  + / +  + 

 +  +  + / +  + 

Delta/Lambda

 +  + 

 +  + 

Omicron

 +  +  + / +  + 

 +  +  + 

Back to article page